ARCHIVES

FDA Committee Approves NDA for Mitxantrone

This article is from The Cancer Letter archive.

Vol. 12 No. 12 | March 21, 1986

Download PDF Visit The Full Archive

Related Articles

Continuing Progress Reported On Breast Cancer Treatment; Mammography Controversy Cooled

November 26, 1976

Drug Development Committee Demands, Gets Greater Voice In Contract Awards, Review of Unsolicited Proposals, Suggests RFP For New Screening Systems

January 2, 1976

Only Seven Of 66 “Benign” Breast Cancer Turn Out to Be Doubtful

November 25, 1977

Chop Analysis Shows Program Had Major Impact In Communities

January 25, 1985

IOM Recommends FDA Consolidate Each Drug’s Lifetime History

May 4, 2012

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

October 28, 2011